No abstract

The incidence of parental loss by death before the age of 15 was investigated in a series of 200 depressed patients, sub-divided into unipolars, bipolars and neurotic-reactive depressives, and in their healthy siblings at risk. The age of onset of illness of patients who had lost a parent before 15 was compared with that of depressed controls. No excess of parental loss at any age was found in any of the patient sub-groups, as compared with their healthy siblings, nor did parental loss affect the age of onset of later depression. The results do not support the assumption that the loss of either parent by death in early childhood is significantly associated with depression in adult life, though parental death may be an important variable for individual patients.

In a double blind controlled cross-over trial on 20 healthy volunteers, the anticholinergic side-effects of single doses of amitriptyline (75 mg), zimelidine (100 mg), maprotiline (75 mg), and placebo were compared. Anticholinergic side-effects were determined by means of self-rating of dryness in the mouth (visual analogue scale), determination of unstimulated and stimulated saliva secretion rate and accommodation range. There were no significant effects recorded after intake of placebo, which supports the test-retest reliability and the validity of the methods. Amitriptyline produced the most pronounced anticholinergic side-effects followed by maprotiline and zimelidine in decreasing order. There were no significant correlations between self-rating of dry mouth and saliva secretion rate or between accommodation ability and saliva secretion rate.

In a double-blind controlled cross-over trial on 20 healthy volunteers, the acute effects of single doses of amitriptyline (75 mg), zimelidine (100 mg), maprotiline (75 mg), and placebo were tested on saliva composition. From the current knowledge of the physiological regulation of the salivary glands and the different specificities of the three drugs, different responses from the salivary glands could be expected. As all three drugs have anticholinergic effects that influence the saliva secretion, the concentrations of secreted saliva components had to be recalculated with regard to changes in secretion rate. No changes in saliva composition were recorded after the intake of placebo. The most pronounced changes were observed after amitriptyline intake. Amitriptyline caused increases in the concentrations of proteins, glycoproteins, calcium and potassium. Zimelidine initially decreased the concentrations of glycoproteins and increased the concentration of calcium. Maprotiline increased the concentrations of proteins and sodium. Most of the results fit in well with the theories about facilitated serotoninergic and adrenergic transmission during treatment with antidepressants.

– In a double‐blind, controlled, cross‐over trial on 10 healthy volunteers, the effects of daily doses of maprotiline (75 mg) and zimelidine (100 mg) over a 14‐day period were tested on saliva secretion rate and saliva composition. Based on current knowledge of salivary gland physiology and the difference in specificity between the two drugs, differences in salivary gland response could be expected. Since both drugs have anticholinergic effects which influence saliva secretion rate, the measured component concentrations had to be recalculated with regard to dependencies of secretion rate. Maprotiline, but not zimelidine, caused strong inhibition of secretion rate and accommodation ability. Maprotiline consistently caused around 50% increases in concentrations of the following saliva components: protein, amylase, fucose, hexose, sialic acid and potassium. The effects of zimelidine were less pronounced and resulted in initial increases of most organic components. 14 and 18 h after the intake of the drug these increases had disappeared and some of the components instead showed decreased concentrations. The results are consistent with current theories about facilitated serotoninergic and noradrenergic transmissions during treatment with antidepressants.